Lanreotide Acetate | Health Canada | Drug Product Database | DPD | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Lanreotide Acetate
Canada

PharmaCompass Sponsored Ads

Contact Supplier

ChemWerth Lanreotide Acetate

Contact Supplier

Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.

Contact Supplier

Temad- We think of world-class quality.

Contact Supplier

Lanreotide Acetate

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

26 API Suppliers, 8 USDMF, 6 NDC API, 18 Listed Suppliers, $ API Reference Price

26 API Suppliers
8 USDMF
6 NDC API
18 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

31 Drugs in Development

31 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

164 FDF Dossiers, 9 FDA Orange Book, 113 Europe, 6 Canada, 24 Australia, 3 South Africa, 9 Listed Dossiers

164 FDF Dossiers
9 FDA Orange Book
113 Europe
6 Canada
24 Australia
3 South Africa
9 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;SUBCUTANEOUS - EQ 120MG BASE/0.5ML (EQ 120MG BASE/0.5ML), SOLUTION;SUBCUTANEOUS - EQ 60MG BASE/0.2ML (EQ 60MG BASE/0.2ML), SOLUTION;SUBCUTANEOUS - EQ 90MG BASE/0.3ML (EQ 90MG BASE/0.3ML), SOLUTION;SUBCUTANEOUS - EQ 120MG BASE/0.5ML (EQ 120MG BASE/0.5ML), SOLUTION;SUBCUTANEOUS - EQ 60MG BASE/0.2ML (EQ 60MG BASE/0.2ML), SOLUTION;SUBCUTANEOUS - EQ 90MG BASE/0.3ML (EQ 90MG BASE/0.3ML)

SOLUTION;SUBCUTANEOUS - EQ 120MG BASE/0.5ML (EQ 120MG BASE/0.5ML)
SOLUTION;SUBCUTANEOUS - EQ 60MG BASE/0.2ML (EQ 60MG BASE/0.2ML)
SOLUTION;SUBCUTANEOUS - EQ 90MG BASE/0.3ML (EQ 90MG BASE/0.3ML)
SOLUTION;SUBCUTANEOUS - EQ 120MG BASE/0.5ML (EQ 120MG BASE/0.5ML)
SOLUTION;SUBCUTANEOUS - EQ 60MG BASE/0.2ML (EQ 60MG BASE/0.2ML)
SOLUTION;SUBCUTANEOUS - EQ 90MG BASE/0.3ML (EQ 90MG BASE/0.3ML)

DIGITAL CONTENT

2 Data Compilation #PharmaFlow, 18 News #PharmaBuzz

2 Data Compilation #PharmaFlow
18 News #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 21 Regulatory FDF Prices, 11 Annual Reports

2 US Medicaid Prescriptions
21 Regulatory FDF Prices
11 Annual Reports

MARKET PLACE

5 APIs, 5 FDF Dossiers

5 APIs
5 FDF Dossiers

PATENTS & EXCLUSIVITIES

6 Health Canada Patents

6 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 Others

3 Others

$ API Ref.Price (USD/KG) : 431,380 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

6 All

01 3ADVANZ PHARMA CANADA INC.

02 3IPSEN BIOPHARMACEUTICALS CANADA INC

filter Active Ingredients Reset all filters

6 All

01 6LANREOTIDE (LANREOTIDE ACETATE)

filter Dosage Form Reset all filters

6 All

01 6SOLUTION (EXTENDED RELEASE)

filter Brand Name Reset all filters

6 All

01 3MYTOLAC

02 3SOMATULINE AUTOGEL

Bachem Lanreotide Acetate

List of Suppliers

Product Main Page

01

IPSEN BIOPHARMACEUTICALS CANADA INC

Fall Technical Meeting

Not Confirmed

IPSEN BIOPHARMACEUTICALS CANADA INC

Fall Technical Meeting

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

LANREOTIDE (LANREOTIDE ACETATE)

Brand Name : SOMATULINE AUTOGEL

Dosage Form : SOLUTION (EXTENDED RELEASE)

Dosage Strength : 60MG/SYR

Packaging : 60MG/SYRINGE

Approval Date :

Application Number : 2283395

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

IPSEN BIOPHARMACEUTICALS CANADA INC

Fall Technical Meeting

Not Confirmed

IPSEN BIOPHARMACEUTICALS CANADA INC

Fall Technical Meeting

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

LANREOTIDE (LANREOTIDE ACETATE)

Brand Name : SOMATULINE AUTOGEL

Dosage Form : SOLUTION (EXTENDED RELEASE)

Dosage Strength : 90MG/SYR

Packaging : 90MG/SYRINGE

Approval Date :

Application Number : 2283409

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

IPSEN BIOPHARMACEUTICALS CANADA INC

Fall Technical Meeting

Not Confirmed

IPSEN BIOPHARMACEUTICALS CANADA INC

Fall Technical Meeting

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

LANREOTIDE (LANREOTIDE ACETATE)

Brand Name : SOMATULINE AUTOGEL

Dosage Form : SOLUTION (EXTENDED RELEASE)

Dosage Strength : 120MG/SYR

Packaging : 120MG/SYRINGE

Approval Date :

Application Number : 2283417

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

ADVANZ PHARMA CANADA INC.

Country

Fall Technical Meeting

Not Confirmed

ADVANZ PHARMA CANADA INC.

Country

Fall Technical Meeting

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Country

Virtual Booth

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

LANREOTIDE (LANREOTIDE ACETATE)

Brand Name : MYTOLAC

Dosage Form : SOLUTION (EXTENDED RELEASE)

Dosage Strength : 60MG/SYR

Packaging :

Approval Date :

Application Number : 2555867

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

05

ADVANZ PHARMA CANADA INC.

Country

Fall Technical Meeting

Not Confirmed

ADVANZ PHARMA CANADA INC.

Country

Fall Technical Meeting

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Country

Virtual Booth

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

LANREOTIDE (LANREOTIDE ACETATE)

Brand Name : MYTOLAC

Dosage Form : SOLUTION (EXTENDED RELEASE)

Dosage Strength : 90MG/SYR

Packaging :

Approval Date :

Application Number : 2555875

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

06

ADVANZ PHARMA CANADA INC.

Country

Fall Technical Meeting

Not Confirmed

ADVANZ PHARMA CANADA INC.

Country

Fall Technical Meeting

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Country

Virtual Booth

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

LANREOTIDE (LANREOTIDE ACETATE)

Brand Name : MYTOLAC

Dosage Form : SOLUTION (EXTENDED RELEASE)

Dosage Strength : 120MG/SYR

Packaging :

Approval Date :

Application Number : 2555883

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!